Seegene Ownership
096530 Stock | KRW 24,800 750.00 3.12% |
Seegene |
Seegene Stock Ownership Analysis
About 31.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 140.12. Seegene had not issued any dividends in recent years. The entity had 2:1 split on the 23rd of April 2021. Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Seegene please contact Richard Creager at 82 2 2240 4000 or go to https://www.seegene.com.Seegene Outstanding Bonds
Seegene issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Seegene uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Seegene bonds can be classified according to their maturity, which is the date when Seegene has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.